Fig. 4From: Hsa-miR-375 is a predictor of local control in early stage breast cancer a In a time-to-event analysis (event = local relapse), hsa-miR-375 was able to separate the relapse from the control group (log-rank p = 0.003): high expression levels were correlated with a higher probability of local relapse. b In a subgroup analysis of only ERα-positive patients, the differentiation between relapse and control based on the levels of hsa-miR-375 was more pronounced (log-rank p = 0.0005)Back to article page